Determination of Cholesterol and Triglyceride Concentrations in Serum Extracellular Vesicles Using Commercial Kits
1Institute of Higher Nervous Activity and Neurophysiology RAS,
5A Butlerova str., Moscow, 117485 Russia; *e-mail: al_yakovlev@ihna.ru
2Scientifc and Practical Psychoneurological Center named after Z.P. Solovy’ov DZM,
43 Donskaya str., Moscow, 115419 Russia
3Moscow Institute of Physics and Technology (State University), 9 Institutskiy per., Dolgoprudny,Moscow region, Russia
Keywords:small extracellular vesicles; blood serum; dynamic light scattering; cholesterol; triglycerides
DOI:10.18097/BMCRM00148
Exosomes and microvesicles, collectively referred to as small extracellular vesicles (sEV) are vesicles with an average size of about 100-150 nm. Currently, the role of sEV in various aspects of signaling in the body is being actively investigated; in addition, sEV can often serve as markers of various pathologies. The active study of the sEV composition is continuing. In this study we have demonstrated that in sEV it is possible to determine cholesterol and triglycerides concentration by using commercial kits designed for serum. The technique was tested on sEV from the blood of patients diagnosed with depression and on healthy volunteers. No differences were found in the concentration of cholesterol and triglycerides in mEV from the blood serum of depressed patients and the control group. The concentration of cholesterol and triglycerides in the samples is several times higher than the sensitivity threshold of the methods set by the manufacturer of the kits.
FUNDING
The article was prepared in full within the state assignment of Ministry of Education and Science of the Russian Federation № АААА-А19-119071990046-9 “Neurogenetics”
REFERENCES
- Bavisotto, C. C. et al. (2019) Extracellular Vesicle-Mediated Cell-Cell Communication in the Nervous System: Focus on Neurological Diseases. Int. J. Mol. Sci., 20(2), 434. DOI
- Hoshino, A. et al., (2015) Tumour exosome integrins determine organotropic metastasis. Nature, 527(7578), 329-335. DOI
- Fiandaca, M. S. et al. (2015) Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study. Alzheimers & Dementia, 11,(6), 600-607. DOI
- Kamerkar, S. et al. (2017) Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature, 546(659), 498-503. DOI
- Osteikoetxea, X. et al. (2015) Improved Characterization of EV Preparations Based on Protein to Lipid Ratio and Lipid Properties. Plos One, 10(3), e0121184. DOI
- Lai, R. C. et al. (2010) Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Research, 4(3), 214-222. DOI
- Wubbolts, R. et al. (2003) Proteomic and biochemical analyses of human B cell-derived exosomes - Potential implications for their function and multivesicular body formation. Journal of Biological Chemistry, 278(13), 10963-10972. DOI
- Record, M., Carayon K., Poirot M., Silvente-Poirot, S. (2014) Exosomes as new vesicular lipid transporters involved in cell-cell communication and various pathophysiologies. Biochimica Et Biophysica Acta-Molecular and Cell Biology of Lipids, 1841(1), 108-120. DOI
- Skotland, T., Hessvik, N. P., Sandvig, K., Llorente, A. (2019) Thematic Review Series: Exosomes and Microvesicles: Lipids as Key Components of their Biogenesis and Functions Exosomal lipid composition and the role of ether lipids and phosphoinositides in exosome biology. Journal of Lipid Research, 60(1), 9-18. DOI
- Banks, W. A., Sharma, P., Bullock, K. M., Hansen, K. M., Ludwig, N., Whiteside, T. L. (2020) Transport of Extracellular Vesicles across the Blood-Brain Barrier: Brain Pharmacokinetics and Effects of Inflammation. International Journal of Molecular Sciences, 21(12), 4407. DOI
- Goetzl, E. J. et al. (2016) Cargo proteins of plasma astrocyte-derived exosomes in Alzheimer's disease. Faseb Journal, 30(1), 3853-3859. DOI
- Morad, G. et al. (2019) Tumor-Derived Extracellular Vesicles Breach the Intact Blood-Brain Barrier via Transcytosis. Acs Nano, 13(12), 13853-13865. DOI
- Jow, G. M., Yang, T. T., Chen, C. L. (2006) Leptin and cholesterol levels are low in major depressive disorder, but high in schizophrenia. Journal of Affective Disorders, 90(1), pp. 21-27. DOI
- Liu, T. et al. (2015) A Meta-Analysis of Oxidative Stress Markers in Depression. Plos One, 10(10), e0138904. DOI
- Sarchiapone, M. et al. (2001) Cholesterol and serotonin indices in depressed and suicidal patients. Journal of Affective Disorders, 62(3), 217-219. DOI
- Lalovic, A. et al. (2004) Investigation of completed suicide and genes involved in cholesterol metabolism. Journal of Affective Disorders, 79(1-3), 25-32. DOI
- Ng, F., Berk, M., Dean, O., Bush, A. I. (2008) Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. International Journal of Neuropsychopharmacology, 11(6), 851-876. DOI
- Maes, M., Galecki, P., Chang, Y. S., Berk, M. (2011) A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 35(3), 676-692. DOI
- Lutjohann, D. et al. (2000) Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients. Journal of Lipid Research, 41(2), 195-198. DOI